Table:
Early Surveys(2000-2004)N=108	Late Surveys(2006-2013)N=116	p value
Gender (female)	28.7%	31%	0.7
Median Age	70.52±13.67	68.95±13.22	0.35
Age above >75 years	47.22%	38.79%	0.2
Cardiovascular risk factor and cardiovascular history
History of Diabetes	28%	41.7%	0.03
History of HTN	50.5%	64.9%	0.029
History of dyslipidemia	31.8%	63.6%	0.001
Family history of CAD	10.3%	18.1%	0.11
Mean BMI	26.43±4.49	27.68±5.29	0.23
History of MI	33.6%	30.1%	0.57
Past PCI	29.9%	7.8%	0.1
Past CABG	4.7%	21.2%	0.33
Past CAV/TIA	19.4%	8.8%	0.02
History of CHF	13.1%	16.8%	0.58
History of CRF	13.9%	14.9%	0.82
History of PVD	13.1%	10.6%	0.57
Chronic Medication
ASA	52.5%	44.9%	0.34
Clopidogrel	1.6%	5.7%	0/19
BB	38.1%	39.8	0.82
ACEi	28.6%	38.1%	0.2
CCB	19.4%	18.9%	0.92
Nitrate	28.6%	9.4%	0.001
Lipid lowering agents	15.7%	37.1%	0.0003
Insulin	3.2%	4.5%	0.65
Anti-Hyperglycemic	15.9	29.5	0.04

Parse the figure content behind with markdown code: |  | Early Surveys(2000-2004)N=108 | Late Surveys(2006-2013)N=116 | p value | 
 | --- | --- | --- | --- | 
 | Gender (female) | 28.7% | 31% | 0.7 | 
 | Median Age | 70.52±13.67 | 68.95±13.22 | 0.35 | 
 | Age above >75 years | 47.22% | 38.79% | 0.2 | 
 | <COLSPAN=4> Cardiovascular risk factor and cardiovascular history | 
 | History of Diabetes | 28% | 41.7% | 0.03 | 
 | History of HTN | 50.5% | 64.9% | 0.029 | 
 | History of dyslipidemia | 31.8% | 63.6% | 0.001 | 
 | Family history of CAD | 10.3% | 18.1% | 0.11 | 
 | Mean BMI | 26.43±4.49 | 27.68±5.29 | 0.23 | 
 | History of MI | 33.6% | 30.1% | 0.57 | 
 | Past PCI | 29.9% | 7.8% | 0.1 | 
 | Past

CABG | 4.7% | 21.2% | 0.33 | 
 | Past CAV/TIA | 19.4% | 8.8% | 0.02 | 
 | History of CHF | 13.1% | 16.8% | 0.58 | 
 | History of CRF | 13.9% | 14.9% | 0.82 | 
 | History of PVD | 13.1% | 10.6% | 0.57 | 
 | <COLSPAN=4> Chronic Medication | 
 | ASA | 52.5% | 44.9% | 0.34 | 
 | Clopidogrel | 1.6% | 5.7% | 0/19 | 
 | BB | 38.1% | 39.8 | 0.82 | 
 | ACEi | 28.6% | 38.1% | 0.2 | 
 | CCB | 19.4% | 18.9% | 0.92 | 
 | Nitrate | 28.6% | 9.4% | 0.001 | 
 | Lipid lowering agents | 15.7% | 37.1% | 0.0003 | 
 | Insulin | 3.2% | 4.5% | 0.65 | 
 | Anti-Hyperglycemic | 15.9 | 29.5 | 0.04 |